Gondé Henri, Laurent Marc, Gillibert André, Sarsam Omar-Matthieu, Varin Rémi, Grimandi Gaël, Peillon Christophe, Baste Jean-Marc
Department of Pharmacy, Rouen University Hospital, Rouen, France.
Department of Epidemiology and Public Health, Rouen University Hospital, Rouen, France.
Interact Cardiovasc Thorac Surg. 2017 Sep 1;25(3):469-475. doi: 10.1093/icvts/ivx149.
Minimally invasive procedures are used for the surgical treatment of lung cancer. Two techniques are proposed: video-assisted thoracic surgery or robotic-assisted thoracic surgery. Our goal was to study the economic impact of our long-standing program for minimally invasive procedures for major lung resection.
We conducted a single-centre, 1-year prospective cost study. Patients who underwent lobectomy or segmentectomy were included. Patient characteristics and perioperative outcomes were collected. Medical supply expenses based on the microcosting method and capital depreciation were estimated. Total cost was evaluated using a national French database.
One hundred twelve patients were included, 57 with and 55 without robotic assistance. More segmentectomies were performed with robotic assistance. The median length of stay was 5 days for robotic-assisted and 6 days for video-assisted procedures (P = 0.13). The duration of median chest drains (4 days, P = 0.36) and of operating room time (255 min, P = 0.55) was not significantly different between the groups. The overall conversion rate to thoracotomy was 9%, significantly higher in the video-assisted group than in the robotic group (16% vs 2%, P = 0.008). No difference was observed in postoperative complications. The cost of most robotic-assisted procedures ranged from €10 000 to €12 000 (median €10 972) and that of most video-assisted procedures ranged from €8 000 to €10 000 (median €9 637) (P = 0.007); median medical supply expenses were €3 236 and €2 818, respectively (P = 0.004). The overall mean cost of minimally invasive techniques (€11 759) was significantly lower than the mean French cost of lung resection surgical procedures (€13 424) (P = 0.001).
The cost at our centre of performing minimally invasive surgical procedures appeared lower than the cost nationwide. Robotic-assisted thoracic surgery demonstrated acceptable additional costs for a long-standing program.
微创手术用于肺癌的外科治疗。提出了两种技术:电视辅助胸腔镜手术或机器人辅助胸腔镜手术。我们的目标是研究我们长期开展的主要肺切除微创手术项目的经济影响。
我们进行了一项单中心、为期1年的前瞻性成本研究。纳入接受肺叶切除术或肺段切除术的患者。收集患者特征和围手术期结果。根据微观成本核算方法和资本折旧估算医疗用品费用。使用法国国家数据库评估总成本。
纳入112例患者,57例接受机器人辅助,55例未接受机器人辅助。机器人辅助下进行的肺段切除术更多。机器人辅助手术的中位住院时间为5天,电视辅助手术为6天(P = 0.13)。两组之间胸腔引流管中位留置时间(4天,P = 0.36)和手术室时间(255分钟,P = 0.55)无显著差异。总体开胸转换率为9%,电视辅助组显著高于机器人组(16%对2%,P = 0.008)。术后并发症方面未观察到差异。大多数机器人辅助手术的成本在10000欧元至12000欧元之间(中位值10972欧元),大多数电视辅助手术的成本在8000欧元至10000欧元之间(中位值9637欧元)(P = 0.007);医疗用品中位费用分别为3236欧元和2818欧元(P = 0.004)。微创手术的总体平均成本(11759欧元)显著低于法国肺切除手术的平均成本(13424欧元)(P = 0.001)。
我们中心进行微创手术的成本似乎低于全国成本。对于长期项目,机器人辅助胸腔镜手术显示出可接受的额外成本。